Alcon Inc
ALC: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$81.00 | Bmfln | Xrlnczl |
Alcon Enjoys Healthy Demand and Recovering Environment; Reaffirms Dominance in Vision Care Space
Business Strategy and Outlook
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical.